Submit Deal

Paul Jin

Partner at Goodwin Procter

Lawyer

Washington, DC

Deal Bio

Total Deals36

Valued Deals28

Total Value£44,375M

Avg. Deal Size£1,585M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (36)

Sort

United States

Software

PrivateAcquisitionPrivate EquityPrivate EquityMajority

target

Qualtrics International

bidder

Sap

£6,164m

40 dealmakers

United States

Health Care Services

AcquisitionMergerPublicPrivate Equity

target

Civitas Solutions

bidder

Centerbridge Partners

£1,107m

41 dealmakers

United States

Water

AcquisitionMergerMajorityPublicPrivate EquityDomestic

target

Aquaventure Holdings

bidder

Culligan International Company

£845m

71 dealmakers

United States

Diversified Financials

AcquisitionMergerPrivateMajorityPrivate EquityDomesticDe-SPAC

target

Open Lending

bidder

True Wind Capital

£993m

35 dealmakers

United States

Electronic Components and Equipment

PrivateMajorityAcquisitionPrivate EquityDomestic

target

Micross Components

bidder

Corfin Industries

value n/a

48 dealmakers

Germany

Pharmaceuticals

MajorityAcquisitionPrivatePrivate EquityCross BorderReverse TakeoverDe-SPAC

target

Immatics Biotechnologies

bidder

Arya Sciences Acquisition Corp

£288m

73 dealmakers

United States

Water

Private EquityAcquisitionMajorityPrivateDomestic

target

Seven Seas Water

bidder

Morgan Stanley Infrastructure Partners

value n/a

80 dealmakers

United States

Digital Services

AcquisitionPrivateMajorityDomestic

target

Bluejeans Network

bidder

Verizon Communications

£321m

95 dealmakers

United States

Medical Services

AcquisitionPrivatePrivate EquityMajorityCross Border

target

Corvidia Therapeutics

bidder

Novo Nordisk

£1,646m

55 dealmakers

United States

Software

PrivateAcquisitionMajorityPrivate EquityDisposal

target

ENGAGIO

bidder

DEMANDBASE

value n/a

26 dealmakers

United States

Software

DomesticPrivateAcquisitionPrivate EquityMajority

target

Reflexis Systems

bidder

Zebra Technologies Corporation

£447m

46 dealmakers

United Kingdom

Biotechnology

PrivateMajorityAcquisitionCross BorderPrivate Equity

target

Kandy Therapeutics

bidder

Bayer

£326m

100 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy